Found 20 results
Author Title [ Type(Asc)] Year
Filters: Author is Vignati, L  [Clear All Filters]
Journal Article
A. Girach, Aiello, L., Milton, R., Davis, M., Danis, R., Zhi, X., Sheetz, M., and Vignati, L., Sustained Moderate Visual Loss as a Predictive End Point for Visual Loss in Non-Proliferative Diabetic Retinopathy, Eye (Lond), vol. 23, pp. 209-214, 2009.
R. C. Milton, Aiello, L. P., Davis, M. D., Sheetz, M. J., Arora, V., Vignati, L., Girach, A., and Group, T. P. K. C. - D. R. S. St, Results of the Protein Kinase C b Inhibitor Diabetic Retinopathy Study (PKC-DRS), 2004.
R. C. Milton, Aiello, L. P., Davis, M. D., Sheetz, M. J., Arora, V., and Vignati, L., Initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS), 2003.
L. P. Aiello, Davis, M. D., Milton, R. C., Sheetz, M. J., Arora, V., and Vignati, L., Initial results of the Protein Kinase C beta Inhibitor Diabetic Macular Edema Study (PKC-DMES), 2003.
R. C. Milton, Aiello, L. P., Davis, M. D., Arora, V., Vignati, L., Sheetz, M. J., and Group, T. P. K. C. - D. R. S. St, Initial results of the Protein Kinase C b Inhibitor Diabetic Retinopathy Study (PKC-DRS), 2003.
A. Brucker, Aiello, L. P., Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Group, R. C. Milton for, Effect of the orally administered PKC b Inhibitor, Ruboxistaurin, on sustained moderate visual loss in the PKC-DRS2 Study, 2006.
L. Vignati, Sheetz, M. J., Girach, A., Zhi, X., Davis, M. D., and Milton, R. C., Effect of the Oral Protein Kinase C b Inhibitor, Ruboxistaurin, on Visual Acuity in the PKC-DRS2 Study, 2006.
M. J. Sheetz, Aiello, L. P., Davis, M. D., Milton, R. C., Arora, V., Hu, K., Girach, A., and Vignati, L., The Effect of Ruboxistaurin (RBX), a PKC b Inhibitor, on Visual Acuity (VA) Loss Due to Diabetic Macular Edema (DME), 2004.
L. Aiello, Davis, M., Girach, A., Kles, K., Milton, R., Sheetz, M., Vignati, L., and Zhi, X., Effect of Ruboxistaurin on Visual Loss in Patients With Diabetic Retinopathy, Ophthalmology, vol. 113, no. 12, pp. 2221-2230, 2006.
M. Davis, Sheetz, M., Aiello, L., Milton, R., Danis, R., Zhi, X., Girach, A., Jimenez, M., Vignati, L., and Group, P. K. C. - D. R. S. Study, Effect of Ruboxistaurin on the Visual Acuity Decline Associated with Long-Standing Diabetic Macular Edema, Invest Ophthalmol Vis Sci, vol. 50, pp. 1-4, 2009.
P. M. Dodson, Aiello, L. P., Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., PKC-DRS, R. C. Milton for, and Groups, P. K. C. - D. R. S. Study, Effect of Ruboxistaurin on diabetic macular edema and visual loss: Integrated analysis of the PKC-DRS and PKC-DRS2, 2006.
M. J. Sheetz, Aiello, L. P., Davis, M. D., Milton, R. C., Arora, V., Hu, K., Girach, A., and Vignati, L., Diabetic Macular Edema - Relationship of Visual Acuity to Involvement of the Center of the Macula, 2004.
M. J. Sheetz, Aiello, L. P., Davis, M. D., Milton, R. C., Arora, V., Hu, K., Girach, A., and Vignati, L., Diabetic Macular Edema - Relationship of Visual Acuity to Involvement of the Center of the Macula, 2004.
Conference Paper
L. P. Aiello, Davis, M. D., Milton, R. C., Sheetz, M. J., Arora, V., Vignati, L., and Girach, A., Initial Results of the Protein Kinase C b Inhibitor Diabetic Macular Edema Study (PKC-DMES), in Program of the European Association for the Study of Diabetes - Eye Complications, Munich, Germany, 2004.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R. C., The Effect of the PKC b Inhibitor Ruboxistaurin on Moderate Visual Loss: The PKC-DRS2 Trial Baseline Characteristics and Preliminary Results, in American Academy of Ophthalmology, Chicago, IL, 2005.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R., Effect of the Orally Administered PKC b Inhibitor, Ruboxistaurin, on Sustained Moderate Visual Loss in the PKC-DRS2 Study, in 29th Annual Meeting of the Macula Society, San Diego, CA, 2006.
L. P. Aiello, Vignati, L., ,, Zhi, X., Davis, M. D., Milton, R. C., and Girach, A., Effect of the Oral PKC b Inhibitor, Ruboxistaurin, on Vision Loss in Patients with Diabetic Retinopathy: The PKC-DRS2 Study Results, in European Association for the Study of Diabetes - Eye Complications, Aarhus, Denmark, 2006.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R. C., Effect of Ruboxistaurin on Diabetic Macular Edema and Visual Loss: Integrated Analysis of the PKC-DRS and PKC-DRS2, in American Diabetes Association 66th Scientific Sessions, Washington, DC, 2006.
M. J. Sheetz, Aiello, L. P., Davis, M. D., Milton, R. C., Hu, K., Girach, A., and Vignati, L., The Effect of Riboxistaurin (RBX) on Visual Acuity Loss Due to Diabetic Macular Edema (DME), in 15th Scientific Meeting of the Eye Complications Study Group of the European Association for the Study of Diabetes (EASDec), Coimbra, Portugal, 2005.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R. C., Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss, in 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG), Berlin, Germany, 2005.